← Back to headlines

FDA OKs New Piflufolastat F 18 Formulation for Prostate Cancer Imaging

This story is reported by Targeted Oncology. Read what other outlets are saying below, then open the original report for full details.

FDA OKs New Piflufolastat F 18 Formulation for Prostate Cancer Imaging · NabkaNews